Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KW-3357 vs Plasma-derived Antithrombin in DIC
NCT01384903Phase 3Completed
- Sponsor
- Kyowa Kirin
- Start
- Jun 2011
- Primary completion
- May 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of antithrombin gamma in disseminated intravascular coagulation (DIC), sponsored by Kyowa Kirin. Started Jun 2011; status: completed.
02
Drugs
antithrombin gamma
03
Conditions
disseminated intravascular coagulation (DIC)
Beyond the preview
Go deeper on NCT01384903.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01384903.